Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib?
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||chronic myeloid leukaemia, clinical trials, dasatinib, imatinib, nilotinib|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > PHARMACOLOGY AND PHARMACEUTICAL SCIENCES (111500)|
|Divisions:||Past > QUT Faculties & Divisions > Faculty of Science and Technology
Past > Schools > Medical Sciences
Past > Schools > Pharmacy
|Deposited On:||19 Jul 2012 06:27|
|Last Modified:||03 Dec 2012 02:06|
Repository Staff Only: item control page